Related Experiment Video
Updated: Aug 16, 2026

Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease
Published on: March 24, 2023
[The role of 99mTc-ciprofloxacin scan in infection imaging]
Abstract:
In this article there is an attempt, to critically review the literature referring to the clinical validity and clinical applications of in vivo imaging of infected areas of our body, with 99mTc-ciprofloxacin (infection). Infection is the product of labeling a broad spectrum antibiotic, ciprofloxacin, with 99mTc. There is increased interest and expectation that this agent will become a useful tool for every day clinical practice, in discriminating, infectious from inflammatory lesions. Although this radiopharmaceutical is not widely available, a number of papers have been published recently regarding clinical and experimental trials with this agent. There is some debate regarding its production procedure and its specificity in discriminating infection from inflammation. Comparison with other infection-imaging agents is described, as well as its clinical validity in specific clinical situations.
Insights
This review examines 99mTc-ciprofloxacin for imaging infections. It discusses the agent's clinical validity and applications in distinguishing infectious from inflammatory lesions.
Area of Science:
- Nuclear medicine
- Radiopharmacology
- Infectious disease imaging
Background:
- 99mTc-ciprofloxacin is a radiopharmaceutical developed for in vivo imaging of infections.
- It is created by labeling the broad-spectrum antibiotic ciprofloxacin with Technetium-99m.
- There is growing interest in its potential to differentiate infectious from inflammatory processes.
Purpose of the Study:
- To critically review the existing literature on the clinical validity and applications of 99mTc-ciprofloxacin.
- To assess its utility in everyday clinical practice for diagnosing infections.
- To explore its specificity in distinguishing infection from inflammation.
Main Methods:
- Literature review of clinical and experimental studies involving 99mTc-ciprofloxacin.
- Analysis of data regarding the production, specificity, and clinical performance of the agent.
- Comparison with other established infection-imaging agents.
Main Results:
- The article reviews published trials on 99mTc-ciprofloxacin.
- Debate exists regarding its production and specificity for infection versus inflammation.
- Its clinical validity in specific scenarios is discussed.
Conclusions:
- 99mTc-ciprofloxacin shows promise as an infection-imaging agent.
- Further research and standardization are needed for widespread clinical adoption.
- Its role in differentiating infectious from inflammatory lesions requires continued evaluation.
More Related Videos
Related Concept Videos
Imaging Studies III: Computed Tomography
Imaging Studies II: Positron Emission Tomography and Scintigraphy
Fundamental Principles of PET
Imaging Studies I: CT and MRI
Description of the Procedures
Computed Tomography (CT) scan:
Computed Tomography (CT) scans use X-ray technology to generate detailed images of bones, organs, and tissues. During the scan, the patient lies on a moving table...
Radiological Investigation I: X-ray and CT
Imaging Studies IV: Magnetic Resonance Imaging
Magnetic Resonance Imaging

